Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma

International Journal of Molecular Medicine

Volumn 3, Issue 2, 1999, Pages 157-161

  Torunishi, ^a   Kuratsu, Jun Ichi ^a   Takeshima, Hideo ^b   Saito, Yoshiki ^a   Kochi, Masato ^a   Ushio, Yukitaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Craniopharyngioma; Ki 67 antigen; MIB 1 labeling index; Recurrence regrowth

Indexed keywords

CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CHILD; CRANIOPHARYNGIOMA; DISEASE COURSE; HUMAN; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; PROGNOSIS; RECURRENT DISEASE;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; CHILD; CHILD, PRESCHOOL; CRANIOPHARYNGIOMA; DISEASE PROGRESSION; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033068609     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bartlett JR:Craniopharyngiomas: an analysis of some aspects of symptomatology, radiology and histology. Brain 94:725-732, 1971.
2. Broggi G, Franzini A, Cajola L and Pluchino F:Cell kinetic investigation in craniopharyngioma: preliminary results and considerations. Pediatr Neurosurg21 (Suppl. 1):21-23, 1994.
3. Brown DC and Gatter KC:Monoclonal antibody Ki-67: its use -inhistopathology. Histopathology 17:489-503, 1990.
4. Cattoretti G, Beckcr MHG, Key G, Duchrow M, Schluter C, Galle J and Gerdes J:Monoclonal antibodies against recombinant .parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363, 1992.
5. De Vile CJ, Grant DB, Kendall BE, Neville BGR, Stanhope R, Watkins KE and Hayward RD:Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? JNeurosurg 85:73-81,1996.
6. Eldevik OP, Blaivas M, Gabrielsen TO, Hald JK and Candler WF:Craniopharyngioma: radiologie and histologie findings and recurrence. Am J Neuroradiol 17:1441-1442,1996.
7. Franzini A, Ferraresi S, Giorgo C, Costa A, Allegranza A and Broggi G:Cell kinetic investigations in brain tumors studied by serial stereotactic biopsy. J Neurooncol 7:373-379,1989.
8. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U and Stein H:Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. JImmunol 133:1710-1715, 1984.
9. Hall PA and Woods AL:Immunohistochemical markers of cellular proliferation: achievements, problem, and prospects. Cell Tissue Kinet 23:505-522,1990.
10. Henke RP, Krüger E, Ayhan N, Hübner D and Hammerer P:Numerical chromosomal aberrations in prostate cancer: correlation with morphology and cell kinetics. Virchows Arch (A) 422:61-66, 1993.
11. Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MS, Gutin PH, Davis RL and De Armond SJ:In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 64:453-459,1986.
12. Hsu SM, Taine L and Fanger H:The use of antiavidin antibody and avidin-biotin peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75:816-821, 1981.
13. Kaplan EL and Meier P:Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958.
14. Kerns BJM, Jordan PA, Faerman LL, Berchuck A, Bast RC and Lay-field LJ:Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis. Am J Clin Pathol 101:192-197, 1994.
15. Key G, Becker MHG, Baron B, Cuchrow M, Schlüter C, Rad HD and Gerdes J:New Ki-67-equivalent murine monoclonal antibodies (MIB1-30) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 basepair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68:629-636, 1993.
16. Kros JM, Hop WCJ, Godschalk JJCJ and Krishnadath KK:Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas. Cancer 78:1107-1113, 1996.
17. Matuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H and Kirino T:Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91:504-510, 1996.
18. Mizouc T, Kawamoto K, Arita K, Kurisu K, Tominaga A and Uozumi T:MIB1 immunopositivity is associated with rapid regrowth of pituitary adenomas. Acta Neurochir 139:426-432, 1997.
19. Montine TJ, Vandersteenhoven JJ, Aguzzi A, Dodge RK, Kerns B-J and Burger PC:Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasm. Neurosurgery 34:674-679, 1994.
20. Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J and Hukui M:MIB1 staining index and scoring of histologie features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer 74:3176-3189, 1994.
21. Price DA, Wilton P, Jonsson P, Albertsson-Wikland K, Chatelain P, Cutfield W and Ranke MB:Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 49:91-97,1998.
22. Regine WF, Mohiuddin M and Kramer S:Long-term results of pediatrie and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 27:13-21,1993.
23. Sheline GE, Wara WM and Smith V:Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6:1215-1228, 1980.
24. Taylor CR, Shan-Rong S, Chaiwun B, Young L, Imam SA and Cote RJ:Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalinparaffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 25:263-270,1994.
25. Veronese SM, Bambacorta M, Gottardi O, Scanzi F, Ferrari M and Lampertico P:Proliferation index as a prognostic marker in breast cancer. Cancer 71:3926-3931,1993.
26. Wintzer HO, Zipfel I, Schulte-Monting J, Hellerich U and von Kleist S:Ki-67 immunostaining of human breast tumors and its relationship to prognosis. Cancer 67:421-428, 1991.
27. Yokoyama M, Matsuda M, Nakasu S, Nakajima M and Handa J:Clinical significance of Ki67 staining index in acoustic neurinoma. Neurol Med Chir 36:698-703,1996.
28. Youssef EM, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H, Watanabe T, Katsura Y, Wanibuchi H and Fukushima S:Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 76:358-366, 1995.